In vivo toxicological evaluation of Anisomycin
| Autor: | Jing Liu, Chunyan Yu, Di Chen, Zhengle Tang, Yu Yu, Jingfang Di, Feiyue Xing |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Male
Ratón Spleen Pharmacology Biology Kidney Toxicology Median lethal dose Drug Administration Schedule Lethal Dose 50 Inhibitory Concentration 50 Mice Random Allocation chemistry.chemical_compound In vivo Toxicity Tests Acute medicine Animals Lymphocytes Lung Anisomycin Mice Inbred BALB C Dose-Response Relationship Drug Body Weight General Medicine Spermatozoa Anti-Bacterial Agents Dose–response relationship medicine.anatomical_structure Liver chemistry Injections Intravenous Immunology Toxicity Female Micronucleus |
| Zdroj: | Toxicology Letters. 208:1-11 |
| ISSN: | 0378-4274 |
| DOI: | 10.1016/j.toxlet.2011.10.001 |
| Popis: | Anisomycin is a pyrrolidine antibiotic isolated from Streptomyces griseolus. Recent studies have shown that Anisomycin as a novel immunosuppressive agent is superior to Cyclosporine A (J. Immunother. 31, 858-870, 2008). In order to make toxicological evaluation of Anisomycin, acute and four-week continuously intravenous toxicity studies were performed in mice. IC(50) value tested on peripheral lymphocytes was 25.44 ng/ml. The calculated LD(50) for Anisomycin was 119.64 mg/kg. The mice were intravenously injected through mouse tail vein with a total dose of 5, 15, 30 and 60 mg/kg/mice of Anisomycin every other day for 4 weeks. Just in the high-dose mice, death of three mice happened and body weight of the mice was significantly decreased. Statistically significant changes in organ index included increases in ratios of the spleen, liver, lung and brain to the body weight, and decrease in ratio of the thymus to the body weight. Changes in clinical biochemistry parameters included increases in the aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities, and decreases in the glucose (GLU) activity. The distinct inflammation appeared in the lung, liver and kidney, and the number and size of megakaryocytes in the spleen were significantly increased. Anisomycin did not induce formation of the peripheral blood micronucleus, but increased the number of micronucleated polychromatic erythrocytes in bone marrow and sperm aberrations. However, the above aberrant changes occurred only in the mice treated with the high-dose Anisomycin. These results indicate that although Anisomycin has no significant side effects at effectively therapeutic doses, its over-dosage may lead to toxicity, particularly pulmo-, nephro- and hepato-toxicity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect